Dare Bioscience (DARE) Misses Q1 EPS by 20c

Dare Bioscience (NASDAQ: DARE) reported Q1 EPS of ($0.20). Revenue for the quarter came in at $15.45 million.

For earnings history and earnings-related data on Dare Bioscience (DARE) click here.

You May Also Be Interested In

• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• JPMorgan Starts Computer Age Management Services (CAMS:IN ) at Overweight
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings